Archive: https://archive.today/GHJWo From the post: >>Patients at high risk of potentially deadly lung cancer will soon be able to receive the world's first ever vaccine designed to prevent the disease. Researchers at University College London and the University of Oxford will run the trial over the next four years, with its first phase expected to commence in summer 2026. The team, who have been awarded over £2million from Cancer Research UK, will investigate the best dose of LungVax to give high risk patients and look for any potential side effects from various doses of the vaccine in the first phase of the trial. Lung cancer is the most common cancer worldwide and the leading cause of cancer death, with around 35,000 deaths in the UK alone each year.